Longevity Health Holdings, Inc. XAGE
0.16
0.00
0.00%
as of 25 Sep
- Market cap
- $1.6M
- P/E
- 0.0×
Follow XAGE
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 109.80% | 127.68% | 130.54% | 142.66% |
+8 more TTM periods Free account |
|
| (286.02%) | (274.36%) | (359.56%) | (199.84%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
77.54% | 97.61% | 117.75% | 147.83% | |
Average Days of Receivables |
4.22 | 9.91 | 6.96 | 87.26 | |
Free Cash Flow per Share |
(0.99) | (1.61) | (2.34) | (2.23) | |
Free Cash Flow |
(2.45) | (3.06) | (3.34) | (3.84) | |
Capital Expenditures |
— | — | (0.01) | (0.04) | |
Piotroski F-Score |
3.00 | 3.00 | 3.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
28.27% | 46.52% | 64.52% | 132.31% | |
Accounts Receivable Turnover |
8.98 | 8.06 | 11.17 | 5.13 | |
Accounts Payable Turnover |
0.14 | 0.15 | 0.19 | 0.15 | |
Inventory Turnover |
0.78 | 0.69 | 1.53 | 1.11 | |
Average Days of Payables |
2,659.04 | 2,515.23 | 2,005.43 | 2,479.16 | |
Days of Inventory on Hand |
320.10 | 366.35 | 429.65 | 602.33 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
29.19% | 36.09% | 41.24% | 57.81% | |
Selling, General and Administrative Expense of Revenue |
369.75% | 405.40% | 383.44% | 395.44% | |
Share Based Compensation of Revenue |
36.06% | 40.34% | 36.22% | 52.50% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.36 | 0.45 | 0.48 | 0.66 | |
Depreciation/Fixed assets |
1.98 | 2.04 | 2.12 | 1.85 | |
Capex/Depreciation |
0.00 | 0.00 | (0.07) | (0.21) | |
Revenue per Share |
0.68 | 0.94 | 1.34 | 0.85 | |
Operating CF per Share |
(0.99) | (1.61) | (2.33) | (2.20) | |
Capex per Share |
0.00 | 0.00 | (0.01) | (0.03) | |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.03 | |
Net Profit Margin |
(404.81%) | (380.71%) | (360.99%) | (393.61%) |
Columns are period end dates